Related Experiment Video

Updated: Jun 2, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Transition from acenocoumarol to warfarin in a 12-year-old child

Nina Hakacova1, Gudrun Björkhem, Katarina Hanséus

  • 1Department of Pediatric Cardiology, Children's Heart Center, Skane University Hospital, Lund, Sweden. nina.hakacova@gmail.com

Congenital Heart Disease
|April 20, 2011
PubMed

Insights

Transitioning between coumadin anticoagulants like warfarin and acenocoumarol can be difficult due to differing drug properties. This case report details a successful transition in a pediatric patient with a prosthetic mitral valve.

Area of Science:

  • Pharmacology
  • Cardiology
  • Pediatrics

Background:

  • Coumadin anticoagulants, such as warfarin and acenocoumarol, vary in availability and usage globally.
  • Switching between these vitamin K antagonists is sometimes necessary but poses challenges due to distinct pharmacokinetic and pharmacodynamic profiles.
  • Pediatric-specific data on transitioning between coumadin anticoagulants is notably absent in existing literature.

Observation:

  • This case report focuses on a 12-year-old child with a prosthetic mitral valve requiring a change in anticoagulant therapy.
  • The patient underwent a transition from acenocoumarol to warfarin, necessitating careful management.

Findings:

  • The transition of anticoagulant therapy from acenocoumarol to warfarin was successfully managed in this pediatric case.
  • This suggests that careful monitoring and individualized dosing strategies can facilitate such transitions in children.

Implications:

  • This case highlights the feasibility of transitioning between coumadin anticoagulants in pediatric patients, despite limited prior research.
  • It underscores the importance of tailored therapeutic approaches for anticoagulation management in children with cardiac conditions.
  • Further research into pediatric anticoagulant transitions is warranted to establish standardized protocols.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...